Several studies have demonstrated that PTX3 expression is associated with progression in various types of cancers, such as head and neck cancer, breast cancer, gastric cancer, melanoma, hepatocellular carcinoma, and cervical cancer. Here, PTX3 is linked to cervical cancer.